RxDoctor Payments Data

Joshua Bederson, MD

Neurosurgery · New York, NYNPI 1821064569

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $9,194 of the $11,962 with a category attached, or 76.9%. Surgical Theater. Inc. accounts for 64.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $7,753 and has fallen 98.8% since, to $92 in 2025.

$11,962in general payments, 2019–2025

Across 12 payments — averaging $996.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgical Theater. Inc.$8K
  • Carl Zeiss Meditec AG$2K
  • Leica Microsystems (schweiz) AG$2K
  • Stryker$266
  • Leica Microsystems CMS GmbH$226
  • Integra Lifesciences Corporation$92
  • plus $17 from 1 others
$195,765in research payments, 2019–2025

Across 1 payment — averaging $195,765 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Leica Microsystems (schweiz) AG$196K
$210,339in ownership & investment interests, 2019–2025

Across 14 payments — averaging $15,024 each. An ownership or investment interest held by the physician or an immediate family member.

  • Imperative Care, Inc$165K
  • Surgical Theater. Inc.$45K

What the payments were for

  • Speaking & faculty fees$2,00017%
  • Travel & lodging$9,19477%
  • Food & beverage$7686%

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Surgical Theater. Inc.2$7,767
Carl Zeiss Meditec AG1$2,000
Leica Microsystems (schweiz) AG2$1,594
Stryker2$266
Leica Microsystems CMS GmbH2$226
Integra Lifesciences Corporation2$92
Medtronic1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurosurgery providers in New Yorkto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$124,354
Medicare patients
67
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurosurgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →